Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Satsuma nets $76.7mm in IPO

Executive Summary

Satsuma Pharmaceuticals Inc. (developing nasally delivered migraine therapeutics) netted $76.7mm in its initial public offering of 5.5mm shares at $15, the mid-point of its anticipated range. The company originally planned to sell 5mm shares.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Nasal
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies